EGFR/CDK2-IN-1 structure
|
Common Name | EGFR/CDK2-IN-1 | ||
---|---|---|---|---|
CAS Number | 2841405-96-5 | Molecular Weight | 387.65 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C19H12BrClO2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of EGFR/CDK2-IN-1EGFR/CDK2-IN-1 (Compound 3b) is an EGFR/CDK2 inhibitor. EGFR/CDK2-IN-1 shows good cytotoxicity against MCF7 and HepG2 cells. EGFR/CDK2-IN-1 can be used in cancer research[1]. |
Name | EGFR/CDK2-IN-1 |
---|
Description | EGFR/CDK2-IN-1 (Compound 3b) is an EGFR/CDK2 inhibitor. EGFR/CDK2-IN-1 shows good cytotoxicity against MCF7 and HepG2 cells. EGFR/CDK2-IN-1 can be used in cancer research[1]. |
---|---|
Related Catalog | |
Target |
EGFR, CDK-2[1]. |
In Vitro | EGFR/CDK2-IN-1 (0-20 μM; 48 h) shows excellent activity in both MCF7 and HepG2 with IC50 values of 4.1 and 3.5 μM, respectively[1]. Cell Cytotoxicity Assay[1] Cell Line: MCF7, HepG2 cells Concentration: 0-20 μM Incubation Time: 48 h Result: Exhibited good cytotoxic activity in breast and liver cancer cells. |
Molecular Formula | C19H12BrClO2 |
---|---|
Molecular Weight | 387.65 |